Eritrea vs Kazakhstan: Previously treated cases tested for RR-/MDR-TB
Eritrea
100.0%
in 2024
Kazakhstan
100.0%
in 2024
Eritrea rank
1st
Kazakhstan rank
1st
Previously treated cases tested for RR-/MDR-TB over time
- Eritrea
- Kazakhstan
How they compare
Eritrea currently reports 100.0% against 100.0% in Kazakhstan, a difference of 0.0%.
Across all 11 years both countries report, Kazakhstan has been ahead every year.
Eritrea ranks 1st and Kazakhstan ranks 1st of 180 countries.
Kazakhstan has averaged higher in every one of the 2 decades both report.
Head to head by decade
| Decade | Eritrea | Kazakhstan | Difference | Ahead |
|---|---|---|---|---|
| 2010s | 56.4% | 90.5% | 34.1% | Kazakhstan |
| 2020s | 100.0% | 100.0% | 0.0% | — |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher previously treated cases tested for rr-/mdr-tb, Eritrea or Kazakhstan?
- Eritrea, at 100.0% against 100.0% in Kazakhstan as of 2024.
- What is the difference in previously treated cases tested for rr-/mdr-tb between Eritrea and Kazakhstan?
- 0.0%, with Eritrea ahead.
- How many years of comparable data are there for Eritrea and Kazakhstan?
- 11 years are reported by both, from 2013 to 2024.
- How do Eritrea and Kazakhstan rank globally for previously treated cases tested for rr-/mdr-tb?
- Eritrea ranks 1st and Kazakhstan ranks 1st of 180 countries.
- Where does this data come from?
- World Health Organization, Global Health Observatory, published as Previously treated cases tested for RR-/MDR-TB (%). Statizoid refreshes it automatically from the source and publishes the full history for both places.